Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure
Circulation Journal · 2024
DOI: 10.1253/circj.cj-24-0205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Journal, 2024. Verfasst von Daniel Sykora und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic School of Graduate Medical Education. Hauptthemen laut MEDLINE: Sarcoidosis, Heart Failure, Systolic, Cardiomyopathies, Stroke Volume. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Center for Clinical and Translational Science.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Cardiac sarcoidosis (CS) may result in systolic heart failure (heart failure with reduced ejection fraction [HFrEF]), but its response to guideline-directed medical therapy (GDMT) remains uncertain. METHODS AND RESULTS: We investigated 881 patients evaluated for CS to identify those with diagnosed CS, left ventricular ejection fraction (LVEF) ≤40% at diagnosis, and follow-up echocardiogram within 11-24 months. Demographics, LVEF, GDMT as quantified by Kansas City Medical Optimization (KCMO) score, and immunosuppressive treatment were recorded. The primary outcome was a composite of event-free survival (unplanned heart failure hospitalization, left ventricular assist device [LVAD]/heart transplant, or death). Seventy-nine (9%) CS patients met the inclusion criteria (35% female, median age 57 years, mean LVEF 30.9%, median New York Heart Association class II [46%], mean number of GDMT agents 1.7, and mean KCMO score 31.8). Most (87%) were treated with immunosuppressive treatment. At follow-up (median 16 months), the mean number of GDMT agents increased to 2.2 (P=0.02), and the mean KCMO score to 70.1 (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mayo Clinic School of Graduate Medical Education.
- Department of Cardiovascular Diseases, Mayo Clinic Rochester.
- Mayo Clinic Alix School of Medicine.
- Department of Diagnostic Radiology, Mayo Clinic Rochester.
- Department of Cardiovascular Diseases, Mayo Clinic Florida.
Förderung
- Center for Clinical and Translational Science
Zitieren
APA
Sykora, D., Bratcher, M., Churchill, R., Kim, B. M., Elwazir, M., Young, K., Ryan, S., Kolluri, N., Abou Ezzeddine, O., Bois, J., Giudicessi, J., Cooper, L., & Rosenbaum, A. (2024). Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure. Circulation Journal. https://doi.org/10.1253/circj.cj-24-0205
Vancouver
Sykora D, Bratcher M, Churchill R, Kim BM, Elwazir M, Young K, et al. Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure. Circulation Journal. 2024. doi:10.1253/circj.cj-24-0205
BibTeX
@article{Sykora2024,
author = {Sykora, Daniel and Bratcher, Melanie and Churchill, Robert and Kim, B Michelle and Elwazir, Mohamed and Young, Kathleen and Ryan, Sami and Kolluri, Nikhil and Abou Ezzeddine, Omar and Bois, John and Giudicessi, John and Cooper, Leslie and Rosenbaum, Andrew},
title = {Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure},
journal = {Circulation Journal},
year = {2024},
doi = {10.1253/circj.cj-24-0205}
}
EUVIMED